Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Cancer. 2014 Aug 22;121(1):69–76. doi: 10.1002/cncr.28971

Table 3.

Hazard ratios for progression-free survival time by Number of Bone Metastasis and Treatment

Number of Bone Mets at Study Enrollment Treatment Number of Patients HR 95% CI
≤ 6 No Strontium 18 1.00
Strontium 19 1.54 (0.66, 3.56)
> 6 No Strontium 22 1.00
Strontium 20 0.68 (0.34, 1.35)

HR = hazard ratio; CI=confidence interval